Contract

Direct Award C - COVID 19 Vaccination Programme for 5–17 years covering Chesterfield, Bolsover and Northeast Derbyshire Locality

  • NHS England

F03: Contract award notice

Notice identifier: 2025/S 000-064890

Procurement identifier (OCID): ocds-h6vhtk-05ae88

Published 13 October 2025, 3:57pm



Section one: Contracting authority

one.1) Name and addresses

NHS England

7&8 Wellington Place

Leeds

LS1 4AP

Contact

Neelam Saroe

Email

neelamsaroe@nhs.net

Country

United Kingdom

Region code

UKE - Yorkshire and the Humber

Internet address(es)

Main address

https://www.england.nhs.uk//

Buyer's address

https://www.england.nhs.uk//

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Direct Award C - COVID 19 Vaccination Programme for 5–17 years covering Chesterfield, Bolsover and Northeast Derbyshire Locality

Reference number

AG25036

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.1.4) Short description

NHS England - Midlands are awarding a contract for the provision of COVID 19 Vaccination Programme for 5–17-year-olds covering Chesterfield, Bolsover and Northeast Derbyshire Locality.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £720

two.2) Description

two.2.2) Additional CPV code(s)

  • 85100000 - Health services

two.2.3) Place of performance

NUTS codes
  • UKF12 - East Derbyshire
Main site or place of performance

Chesterfield, Bolsover and Northeast Derbyshire locality

two.2.4) Description of the procurement

The contract is to deliver a COVID 19 Vaccination Programme for 5–17-year-olds covering Chesterfield, Bolsover and Northeast Derbyshire Locality.

NHS England - Midlands intends to award a contract to the existing provider, Stubley Medical Centre via Direct Award Process C as described in Regulation 9 of the Health Care Services (Provider Selection Regime) Regulations 2023.

Stubley Medical Centre, as the previous incumbent provider, has a proven track record of delivering services in line with the required specification and within the agreed financial envelope. In doing so, they have supported the Covid-19 vaccination outreach programme, improving access for underserved communities and helping to reduce inequalities while maintaining service continuity. Importantly, Stubley Medical Centre administered high numbers of vaccines in this age group, demonstrating both reach and reliability. Their delivery has shown consistency with local and national NHS priorities and contributed to wider social value through efficient use of resources and improved health outcomes.

The approximate lifetime value of the contract is £720.00, and the services are intended to be delivered from 27th October - 31st March 2026.

two.2.5) Award criteria

Quality criterion - Name: The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard / Weighting: 100%

Price - Weighting: 0.00%

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The procurement falls outside the scope of application of the regulations

Explanation:

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 2400hrs (Midnight) 24th October 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

24 September 2025

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Stubley Medical Practice

7 Stubley Drive, Dronfield Woodhouse, Dronfield

Dronfield

S18 8QY

Country

United Kingdom

NUTS code
  • UKF1 - Derbyshire and Nottinghamshire
The contractor is an SME

Yes

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £720

Total value of the contract/lot: £720


Section six. Complementary information

six.3) Additional information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice.

Representations by providers must be made to decision makers by 2400hrs (Midnight) 24th October 2025 to the following email address: england.vaccsadmin-emids@nhs.net

This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

- The decision makers for this process were NHS England’s Regional Commissioning Group and the project group.

- There were no conflicts of interests declared in reaching the decision to award.

- A number of key lines of enquiry (KLoEs) were mapped to the five key criteria set out within the PSR as the criteria against which any provider should be assessed.

1. Quality and innovation
2. Value
3. Integration, collaboration, and service sustainability
4. Improving access, reducing health inequalities, and facilitating choice
5. Social value

Once the KLoEs had been agreed a project group sought evidence based on information taken from several sources to assess the extent to which the KLoEs had been met during the current contract. This evidence was collated, and a summary narrative position was produced to identify the key elements from their local perspectives, and to produce a comprehensive portfolio of evidence to support a direct award under Direct Award Process C. The criteria above were weighted with equal importance and evidence documented accordingly from the provider.

The assessment against each criterion was undertaken based on the current service delivery model and performance. The supplier meets all the requirements specified to the satisfaction of the Commissioner, and it is expected that they will satisfy the requirements of the new contract going forwards.

six.4) Procedures for review

six.4.1) Review body

NHS England Independent Patient Choice and Procurement Panel

London

London

SE1 8UG

Country

United Kingdom

Internet address

https://www.england.nhs.uk/commissioning/how-commissioning-is-changing/nhs-provider-selection-regime/independent-patient-choice-and-procurement-panel/